Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
EverQuote
EVER
$852M
| $228K | ﹤0.01% |
15,452
+2,003
| +15% | +$18.8K |
|
|
CALB
3652
DELISTED
California BanCorp Common Stock
CALB
| $228K | ﹤0.01% |
9,575
+44
| +0.5% | +$1.01K |
|
|
SRDX
3653
DELISTED
Surmodics
SRDX
| $228K | ﹤0.01% |
6,673
+3,059
| +85% | +$103K |
|
3654
Napco Security Technologies
NSSC
$1.36B
| $228K | ﹤0.01% |
8,279
+6,557
| +381% | +$177K |
|
3655
Cullinan Oncology
CGEM
$999M
| $227K | ﹤0.01% |
21,496
+12,502
| +139% | +$152K |
|
3656
iShares US Financials ETF
IYF
$4.58B
| $226K | ﹤0.01% |
+3,000
| New | +$225K |
|
|
PTRA
3657
DELISTED
Proterra Inc. Common Stock
PTRA
| $226K | ﹤0.01% |
60,038
+50,663
| +540% | +$268K |
|
3658
Core Laboratories
CLB
$491M
| $226K | ﹤0.01% |
11,166
-2,614
| -19% | -$50.7K |
|
|
AGNT
3659
AGNT Inc
AGNT
$674M
| $226K | ﹤0.01% |
20,391
-32,503
| -61% | -$394K |
|
|
WE
3660
DELISTED
WeWork Inc.
WE
| $226K | ﹤0.01% |
3,944
+2,743
| +228% | +$257K |
|
|
FRBK
3661
DELISTED
Republic First Bancorp Inc
FRBK
| $224K | ﹤0.01% |
104,379
+10,542
| +11% | +$28K |
|
3662
Telkom Indonesia
TLK
$15B
| $224K | ﹤0.01% |
9,390
+9,332
| +16,090% | +$242K |
|
|
CIR
3663
DELISTED
CIRCOR International, Inc
CIR
| $224K | ﹤0.01% |
9,343
+4,146
| +80% | +$92.8K |
|
3664
United States Lime & Minerals
USLM
$3.21B
| $223K | ﹤0.01% |
7,905
+2,295
| +41% | +$59.2K |
|
3665
Entravision Communication
EVC
$1.02B
| $222K | ﹤0.01% |
46,330
+11,320
| +32% | +$55.5K |
|
3666
Sotera Health
SHC
$5.13B
| $220K | ﹤0.01% |
26,468
+3,297
| +14% | +$24.6K |
|
3667
Inogen
INGN
$182M
| $220K | ﹤0.01% |
11,179
+5,172
| +86% | +$111K |
|
3668
CALL
Thermo Fisher Scientific
TMO
$213B
| $220K | ﹤0.01% |
400
| – | – |
|
|
NPKI
3669
NPK International
NPKI
$1.12B
| $220K | ﹤0.01% |
53,073
+34,624
| +188% | +$127K |
|
3670
Global Water Resources
GWRS
$210M
| $218K | ﹤0.01% |
16,452
+3,077
| +23% | +$38.8K |
|
3671
Invesco Mortgage Capital
IVR
$757M
| $218K | ﹤0.01% |
17,159
+8,593
| +100% | +$105K |
|
|
QUOT
3672
DELISTED
Quotient Technology Inc
QUOT
| $218K | ﹤0.01% |
63,629
-81,813
| -56% | -$231K |
|
3673
Ardmore Shipping
ASC
$712M
| $218K | ﹤0.01% |
15,119
+9,268
| +158% | +$123K |
|
3674
PureCycle Technologies
PCT
$1.41B
| $218K | ﹤0.01% |
32,213
+24,027
| +294% | +$173K |
|
3675
LegalZoom.com
LZ
$1.42B
| $218K | ﹤0.01% |
28,133
-65,847
| -70% | -$571K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.